# FDA recall D-0559-2024

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2024-05-30.

## Product

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore Maryland, Manufactured by: Lupin Limited, Mandideep, India NDC 68180-407-03

## Reason for recall

Failed Content Uniformity Specifications

## Distribution

Nationwide in the US

## Key facts

- **Recall number:** D-0559-2024
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-05-30
- **Report date:** 2024-06-26
- **Termination date:** 2025-04-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0559-2024

## Citation

> AI Analytics. FDA recall D-0559-2024. Retrieved 2026-06-30 from https://api.ai-analytics.org/recall/D-0559-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*